
By combining coral with recombinant human bone morphogenetic protein-2 (rhBMP-2), rhBMP-2/coral composite was obtained in this study. Following implantation of the composite into the muscle pouches of mice, cartilage growth was induced in the pores or on the surface of the implants at one week, woven bone at three week and lamellar bone with bone marrow at six week, and coral was absorbed partially. The induced formation of endochondral bone was time-related and rhBMP-2 dose-related. The results of this study indicate that the composite possesses a superior ability of osteogenesis, and coral acts as one of the most suitable rhBMP-2 slowrelease carriers currently available. The composite will be a new type of bone substitute to be used in orthopaedics and maxillofacial surgery.
Male, Drug Carriers, Time Factors, Dose-Response Relationship, Drug, Bone Morphogenetic Protein 2, Anthozoa, Recombinant Proteins, Mice, Cartilage, Bone Marrow, Osteogenesis, Transforming Growth Factor beta, Bone Morphogenetic Proteins, Bone Substitutes, Materia Medica, Animals, Humans
Male, Drug Carriers, Time Factors, Dose-Response Relationship, Drug, Bone Morphogenetic Protein 2, Anthozoa, Recombinant Proteins, Mice, Cartilage, Bone Marrow, Osteogenesis, Transforming Growth Factor beta, Bone Morphogenetic Proteins, Bone Substitutes, Materia Medica, Animals, Humans
| citations The total number of citations received by all articles of the researcher of interest. | 2 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
